MBMary-Keara Boss

Mary-Keara Boss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mary-Keara Boss has a total of 171 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinically Relevant Motion of Canine Thoracic Tumors Is Seen Between Inspiratory and Expiratory Breath Holds on Computed Tomography Performed for Radiation Treatment Planning

    by Carolynne R. Kruckman‐Gatesy, Susan M. LaRue, Lynn R. Griffin, Mary‐Keara Boss, Gregg Griffenhagen, Sangeeta Rao, Cory N. Wakamatsu, Del Leary

    Advancements in radiation therapy allow for targeting smaller tumor volumes with exceedingly conformal precision. Target motion during the breathing cycle needs to be anticipated. To date, no information exists that characterizes the motion of canine thoracic tumors during the respiratory cycle. The primary purpose of this study is to assess the pattern of motion of thoracic tumors in three‐dimensional (3D) space between inspiratory and expiratory breath holds as a surrogate measurement of the breathing cycle. A secondary aim is to evaluate whether tumor position within the thorax relates to the degree of motion. Fourteen dogs were prospectively enrolled and received thoracic computed tomography (CT) scans with pre‐ and post‐contrast inspiratory and expiratory phases achieved via manual breath holds. Gross tumor volume (GTV) and normal structures were delineated on inspiratory and expiratory image sets, and shifts were measured and analyzed. Smaller tumors had more motion in the dorsoventral direction compared to larger tumors ( p = 0.047; r s = −0.44). The same observation was appreciated in the craniocaudal direction ( p = 0.008; r s = −0.56). Dogs with multiple tumors had more motion in the dorsoventral direction and the craniocaudal direction compared to dogs with solitary tumors ( p = 0.035; p = 0.022). Caudal tumors had significantly more 3D motion ( p < 0.001) and craniocaudal motion ( p < 0.001) compared to cranial tumors, whereas there was significantly more lateral motion ( p < 0.001) between peripheral and central tumors, but no significant difference in 3D motion ( p = 0.24). The variability of tumor motion between canine patients supports individualized assessments of each case to ensure best practice.

  • Open Access

    Local sinonasal and regional nodal effects of lymph node irradiation in a pilot study of dogs with naturally occurring sinonasal tumors

    by Mary-Keara Boss, Laurel B. Darragh, Stavroula Georgiopoulou, Cullen Hart, Lauren G. Harrison, Sophie Hopkins, Madison A. Rivera, Andrej Danczik, Erin Trageser, Lyndah Chow, et al.

  • Open Access

    Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma

    by Victoria Lee Newberry, Mary‐Keara Boss, Del Leary, Tiffany W. Martin

    This retrospective analysis evaluated 12 dogs with hepatocellular carcinoma (HCC) who received stereotactic body radiation therapy (SBRT). Dogs received between 6 and 25 Grey (Gy) per fraction for 1–5 fractions for a total dose of 13–30 Gy. Eleven patients (92%) experienced acute adverse effects (AE), with the majority being VRTOG grade 2–3 stomach/small intestinal AE. Additionally, 70% of patients experienced late AE, with the majority being VRTOG grade 2 stomach/small intestinal AE. Liver‐specific side effects were also observed following SBRT, including VCOG‐CTCAE grade 4 hepatic encephalopathy and grade 5 liver failure. There was a statistically significant correlation between the gross tumour volume (GTV) and the overall survival time (OST; p = 0.02) as well as a significant correlation between the percentage of normal liver affected by the mass and the severity of acute stomach/small intestinal AE ( p = 0.01). Statistically significant correlations were observed between the dose of radiation to the normal liver, starting with a threshold dose of 7 Gy, and an increase of the liver enzyme ALT. Median survival time (MST) of the cohort was 301 days. Dogs with > 28.7% of the liver affected by the mass had a MST of 182 days vs. 419 days for dogs with < 28.7% affected ( p = 0.009). This study suggests parameters for GTV, percentage of liver affected, and dose to normal liver could affect survival and the likelihood for adverse effects and liver enzyme elevation when treating with SBRT.

  • Open Access

    The Effect of Cannabidiol in Conjunction with Radiation Therapy on Canine Glioma Cell Line Transplanted in Immunodeficient Mice

    by Masayasu Ukai, Jade Kurihara, Markos Antonakakis, Krista Banks, Steve Dow, Daniel L. Gustafson, Mary-Keara Boss, Amber Prebble, Stephanie McGrath

    Glioma is a type of neoplasia that spontaneously arises from the glial cells of the brain in humans and dogs, and its prognosis is grave. Current treatment options for glioma include surgery, radiation therapy, chemotherapy, or symptomatic treatment. Evidence has shown that cannabidiol (CBD) may have anticancer, anti-angiogenic, and anti-inflammatory properties in both in vitro and in vivo studies. In this in vivo murine experiment, the canine glioma cell line J3TBG was injected into the frontoparietal cortex of immunodeficient mice using xenogeneic tissue transplantation. A total of 20 mice were randomly assigned to one of four treatment groups—Control group (C), CBD group (CBD), Radiation Therapy group (RT), and CBD plus Radiation Therapy group (CBD + RT). After transplantation of J3TBG, a single fraction of 5.5 Gy RT was administered to the RT and CBD + RT groups, and CBD was administered daily to the CBD and CBD + RT groups. Necropsies were performed to collect blood and brain tissue. Although there was not a statistically significant difference, the survival time among mice were longer in the CBD + RT group than the RT group. These results indicate that CBD may be used as an adjunctive therapy to enhance RT treatment. Larger cohort studies are required to substantiate the hypothesis.


  • Open Access

    Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy

    by Patricia Gualtieri, Lisa Group, David M. Ruslander, Michael W. Nolan, Mary‐Keara Boss

    Hypofractionated radiotherapy (hRT) is often used to treat dogs with oral malignant melanoma (OMM); however, there is no consensus as to whether clinically uninvolved regional lymph nodes should be prophylactically irradiated. The objective of this retrospective study is to compare outcomes for dogs with OMM treated with hRT+/– elective nodal irradiation (ENI). Dogs with nonmetastatic OMM undergoing hRT+/– ENI with a prescription of ≥ 30 Gy were included. Survival statistics were evaluated with Kaplan–Meier curves and log‐rank testing. Univariable and multivariable Cox proportional hazard models were used to assess how survival was impacted by the use of ENI, WHO T‐stage, mitotic count, RT technique, and use of Oncept melanoma vaccine. Data from four institutions and 100 dogs (80 with ENI and 20 without) were included. In the ENI group, nodal and distant metastases were documented in 4 and 30 dogs, respectively. In the non‐ENI group, nodal and distant metastases were documented in 6 and 4 dogs, respectively. There was no significant difference in the 1‐year nodal or distant progression‐free intervals ( p = 0.174, and 0.563, respectively). The only variable maintaining significance on multivariable analysis was T‐stage (overall progression‐free survival, HR 1.393, p = 0.006; overall survival time, HR 1.426, p = 0.005; distant progression‐free interval, HR 1.521, p = 0.033). ENI did not measurably alter the oncologic outcomes in this study population. Results should be interpreted cautiously given the lack of standardised staging/restaging and the heterogenous nature of this clinical population. Future investigations are needed to clarify the role of ENI in the treatment of canine OMM.

  • Identifying Pathogenic Contributors of Radiodermatitis Ameliorated by Smad7-Based Targeting in Canine and Mouse Models

    by Yao Ke, Mary-Keara Boss, Braden Burdekin, Ben-Zheng Li, Li Bian, Donna Wang, Suyan Wang, Ber-In Lee, Patricia Gualtieri, Erin Trageser, et al.


  • JoVE Video Dataset

    by Mary-Keara Boss, Braden Burdekin, Lauren Harrison, Madison Rivera, Adam Harris, Emily Rout, Erin Trageser, Patricia Gualtieri, Ber-In Lee, Steven Dow

    Evaluating the local immune microenvironment of the canine nasal cavity can be important for investigating normal tissue health and disease conditions, particularly those associated with local inflammation. We have optimized a technique to evaluate the local nasal immune microenvironment of dogs via serial nasal lavage. Briefly, with dogs under anesthesia and positioned in sternal recumbency, prewarmed sterile saline is flushed into the affected nostril using a flexible soft rubber catheter. The fluid backflow is collected into conical tubes, and this process is repeated. The fluids containing dislodged cells and proteins are pooled, and the pooled nasal lavage samples are filtered through a cell strainer to remove large debris and mucus. Samples are centrifuged and the cell pellets are isolated for analysis. Once the samples have been processed, analyses that may follow nasal lavage include flow cytometry, transcriptomic analysis of cells via bulk or single-cell RNA seq, and/or quantification of cytokines present in the lavage fluid.

  • Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

    by Mary-Keara Boss, Braden Burdekin, Lauren Harrison, Madison Rivera, Adam Harris, Emily Rout, Erin Trageser, Patricia Gualtieri, Ber-In Lee, Steven Dow

    Evaluating the local immune microenvironment of the canine nasal cavity can be important for investigating normal tissue health and disease conditions, particularly those associated with local inflammation. We have optimized a technique to evaluate the local nasal immune microenvironment of dogs via serial nasal lavage. Briefly, with dogs under anesthesia and positioned in sternal recumbency, prewarmed sterile saline is flushed into the affected nostril using a flexible soft rubber catheter. The fluid backflow is collected into conical tubes, and this process is repeated. The fluids containing dislodged cells and proteins are pooled, and the pooled nasal lavage samples are filtered through a cell strainer to remove large debris and mucus. Samples are centrifuged and the cell pellets are isolated for analysis. Once the samples have been processed, analyses that may follow nasal lavage include flow cytometry, transcriptomic analysis of cells via bulk or single-cell RNA seq, and/or quantification of cytokines present in the lavage fluid.


  • Response of Spontaneous Oral Tumors in Canine Cancer Patients Treated with Stereotactic Body Radiation Therapy (SBRT)

    by Patricia Gualtieri, Ber-In Lee, Amber Beeney, Cullen Hart, Del Leary, Tiffany Martin, Mary-Keara Boss

    The objective of this study is describe outcome and toxicity for dogs with oral tumors, specifically oral malignant melanoma (OMM), squamous cell carcinoma (SCC), and soft tissue sarcoma (STS) after stereotactic body radiation therapy (SBRT). A single institution retrospective study was conducted. Outcomes were analyzed using Kaplan-Meier analysis and Cox proportional hazard analysis. Treatment responses at different time points were evaluated with Pearson's Chi-squared test to identify prognostic factors. Acute and late toxicities were recorded according to VRTOG criteria and were analyzed to identify risk factors. Adverse events other than acute and late toxicities were recorded. A total of 98 patients met the inclusion criteria (OMM n = 37; SCC n = 18; STS n = 43). The SBRT prescription was 1–6 fractions, with a total dose range of 12–40 Gy. Local progression-free survival (PFS) for OMM, SCC, and STS was 187, 253, and 161 days, respectively. Overall PFS was 152 days and median survival time (MST) was 270 days, with no statistical difference between tumor types. The presence of lymph node metastasis and the use of elective nodal irradiation (ENI) were associated with shorted PFS and MST. Severe acute toxicities to organs at risk affected 10/85 (11.8%) of patients. Osteoradionecrosis and oronasal fistula formation occurred in 23/81 (28.4%) of patients and was significantly associated with tumor type (SCC, P = 0.006). SBRT can be offered as a treatment option for oral tumors in dogs. Toxicities were common and warrant risk factor considerations and adjustments to current SBRT protocols.


  • Open Access

    Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model

    by Amber R. Prebble, Bailey Latka, Braden Burdekin, Del Leary, Mac Harris, Daniel Regan, Mary-Keara Boss

    Tyrosine kinase inhibitors (TKIs) may be combined with radiation therapy (RT) to enhance tumor control; however, increased incidences of gastrointestinal (GI) toxicity have been reported with this combination. We hypothesize that toxicity is due to compromised intestinal healing caused by inhibition of vascular repair and proliferation pathways. This study explores underlying tissue toxicity associated with abdominal RT and concurrent sunitinib in a mouse model. Four groups of CD-1 mice were treated with 12 Gy abdominal RT, oral sunitinib, abdominal RT + sunitinib, or sham treatment. Mice received oral sunitinib or the vehicle via gavage for 14 days. On day 7, mice were irradiated with 12 Gy abdominal RT or sham treated. Mice were euthanized on day 14 and intestinal tract was harvested for semiquantitative histopathologic evaluation and immunohistochemical quantification of proliferation (Ki67) and vascular density (CD31). Non-irradiated groups had stable weights while abdominal irradiation resulted in weight loss, with mice receiving RT + SUN having greater weight loss than mice receiving RT alone. Semiquantitative analysis showed significant increases in inflammation in irradiated groups. The difference in the density of CD31+ cells was significantly increased in RT alone compared to SUN alone. Ki67+ density was not significant. In summary, we identify a lack of angiogenic response in irradiated GI tissues when abdominal RT is combined with a TKI, which may correlate with clinical toxicities seen in canine and human patients receiving combined treatment.